|Articles|January 1, 1996

January 1996
Volume 2
Issue 1

Managed Care and HIV Disease

Author(s)Stephen Crystal, PhD

Download PDF: Managed Care and HIV Disease

Articles in this issue

over 30 years ago

Article

Impact of Insurance Type on Receipt of Medical Care by HIV-Infected Men

over 30 years ago

Article

Aspirin After Myocardial Infarction: Patient Experience in a Managed Care Setting

over 30 years ago

Article

The Palliation of Cancer Patients -- Balancing Quality of Life, Cost, and Therapy

over 30 years ago

Article

Modeling the Cost-Effectiveness of Oral Therapy for Nail Fungus

over 30 years ago

Article

Who Keeps the Gender Gate: Ethical and Policy Implications of OB-GYNs as Primary Caregivers

over 30 years ago

Article

The Use of Patient-Perceived Outcome Data in Today's Competitive Managed Care Environment: Suggestions for Providers and Managed Care Organizations

over 30 years ago

Article

Enhancing Skills in Clinical Resource Management: A Managed Care Approach

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Managed Care and HIV Disease

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

AHRQ Grant Freeze Halts Patient Safety Research Nationwide

FDA Advisory Panel Votes Against Approval of Deramiocel for DMD

MASLD, MASH Linked to Higher Mild Cognitive Impairment Risk, Lower Dementia Odds

Addressing Mental Health Challenges Among Black and Latino Boys